BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
kobo biotech limited stock

KOBO BIOTECH LIMITED Share Price

3.49 0.16 (4.80%)
Dec 11 2024 03:21 PM Pharmaceuticals NSE: KOBO

KOBO BIOTECH LIMITED Share Price Update

As of the latest trading session, KOBO BIOTECH LIMITED share price is currently at 3.49, which is up by 0.16 from its previous closing. Today, the stock has fluctuated between 3.49 and 3.49. Over the past year, KOBO BIOTECH LIMITED has achieved a return of 6.73 %. In the last month alone, the return has been 16.84 %. Read More...

KOBO BIOTECH LIMITED Performance

Day Range

Low3.49 High3.49
3.49

52 Week Range

Low 2.66 High 6.01
3.49

KOBO BIOTECH LIMITED Share Price

531541

KOBO

img img img img
No Data Available

Open Price

3.49

Prev. Close

3.33

Volume (Shares)

44155.00

Total traded value

1.54

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

KOBO BIOTECH LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 7.85
PE Ratio (TTM) -1.65
Book Value / Share -55.78
Beta 0.32
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -1.33

KOBO BIOTECH LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 1.35
Net Profit -1.33
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.56
EBITDA -0.32
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 1.26
Net Profit -1.26
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.53
EBITDA -0.25
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.00
Operating Expense 1.23
Net Profit -1.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.52
EBITDA -0.19
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 1.22
Net Profit -1.22
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.51
EBITDA -0.19
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 0.00
Operating Expense 1.24
Net Profit -1.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.51
EBITDA -0.21
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 4.94
Net Profit -4.93
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -2.07
EBITDA -0.85
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 5.57
Net Profit -5.55
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -2.33
EBITDA -1.47
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 15.24
Net Profit -15.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -6.39
EBITDA -10.48
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 19.27
Net Profit -19.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -8.07
EBITDA -2.75
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 21.04
Net Profit -21.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -8.82
EBITDA -0.66
Effective Tax Rate (%) 0.00
Particulars MAR 2014 (Values in Cr)
Book Value / Share 23.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.56
EBITDA Margin -0.64
Particulars MAR 2013 (Values in Cr)
Book Value / Share 39.06
ROE % 16.72
ROCE % 12.63
Total Debt to Total Equity 1.83
EBITDA Margin 10.45
Particulars MAR 2012 (Values in Cr)
Book Value / Share 32.84
ROE % 22.13
ROCE % 17.30
Total Debt to Total Equity 1.82
EBITDA Margin 16.66
Particulars MAR 2011 (Values in Cr)
Book Value / Share 27.29
ROE % 14.91
ROCE % 10.76
Total Debt to Total Equity 2.14
EBITDA Margin 17.19
Particulars MAR 2023 (Values in Cr)
Book Value / Share -53.72
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -51.39
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -45.00
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share -36.92
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2019 (Values in Cr)
Book Value / Share -28.11
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2015 (Values in Cr)
Cash & Short Term Investments 5.64
Total Assets 395.57
Total Liabilities 395.57
Total Equity 53.07
Share Outstanding 22500000
Price to Book Ratio 4.42
Return on Assets (%) -8.80
Return on Capital (%) -15.51
Particulars MAR 2014 (Values in Cr)
Cash & Short Term Investments 16.47
Total Assets 411.67
Total Liabilities 411.67
Total Equity 87.89
Share Outstanding 22500000
Price to Book Ratio 0.44
Return on Assets (%) 3.39
Return on Capital (%) 5.73
Particulars MAR 2013 (Values in Cr)
Cash & Short Term Investments 16.47
Total Assets 411.67
Total Liabilities 411.67
Total Equity 87.89
Share Outstanding 22500000
Price to Book Ratio 0.41
Return on Assets (%) 3.39
Return on Capital (%) 5.73
Particulars MAR 2012 (Values in Cr)
Cash & Short Term Investments 25.13
Total Assets 345.60
Total Liabilities 345.60
Total Equity 75.65
Share Outstanding 22500000
Price to Book Ratio 1.00
Return on Assets (%) 4.37
Return on Capital (%) 8.65
Particulars MAR 2011 (Values in Cr)
Cash & Short Term Investments 2.49
Total Assets 249.98
Total Liabilities 249.98
Total Equity 61.40
Share Outstanding 22500000
Price to Book Ratio 1.26
Return on Assets (%) 3.93
Return on Capital (%) 5.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 75.33
Total Liabilities 75.33
Total Equity -127.98
Share Outstanding 23825000
Price to Book Ratio -0.04
Return on Assets (%) -7.37
Return on Capital (%) -46.83
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 79.18
Total Liabilities 79.18
Total Equity -122.42
Share Outstanding 23825000
Price to Book Ratio -0.11
Return on Assets (%) -19.22
Return on Capital (%) -83.26
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.55
Total Assets 230.58
Total Liabilities 230.58
Total Equity -107.20
Share Outstanding 23825000
Price to Book Ratio -0.16
Return on Assets (%) -8.34
Return on Capital (%) -12.54
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 236.33
Total Liabilities 236.33
Total Equity -87.97
Share Outstanding 23825000
Price to Book Ratio -0.08
Return on Assets (%) -8.88
Return on Capital (%) -18.94
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 239.44
Total Liabilities 239.44
Total Equity -66.96
Share Outstanding 23825000
Price to Book Ratio -0.16
Return on Assets (%) -10.21
Return on Capital (%) -20.82
Particulars MAR 2023 (Values in Cr)
Net Income -5.55
Cash from Operations 0.87
Cash from Investing 0.00
Cash from Financing -0.87
Net change in Cash 0.00
Free Cash Flow 0.87
Particulars MAR 2022 (Values in Cr)
Net Income -15.22
Cash from Operations 93.75
Cash from Investing 25.09
Cash from Financing -120.28
Net change in Cash -1.43
Free Cash Flow 93.75
Particulars MAR 2021 (Values in Cr)
Net Income -19.23
Cash from Operations 2.50
Cash from Investing 0.00
Cash from Financing -1.07
Net change in Cash 1.43
Free Cash Flow 2.50
Particulars MAR 2020 (Values in Cr)
Net Income -21.00
Cash from Operations 14.47
Cash from Investing 0.00
Cash from Financing -14.47
Net change in Cash 0.00
Free Cash Flow 14.47
Particulars MAR 2019 (Values in Cr)
Net Income -24.45
Cash from Operations 20.94
Cash from Investing 0.00
Cash from Financing -20.94
Net change in Cash 0.00
Free Cash Flow 20.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2328.95 49.21 23.58 39453.82 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 3.10
  • 26 Days 2.90
  • 10 Days 3.00
  • 50 Days 2.90
  • 12 Days 3.00
  • 100 Days 3.20
  • 20 Days 2.90
  • 200 Days 4.70
3.33
PIVOT
First Resistance 3.33
Second Resistance 3.33
Third Resistance 3.33
First Support 3.33
Second Support 3.33
Third Support 3.33
RSI 71.54
MACD 0.03
Commodity Channel Index (CCI) 364.22
ADX 18.10
Williams % R 0.00

Over 1 Month

down

16.84

Over 3 Months

down

11.74

Over 6 Months

down

-29.89

Over 1 Year

down

6.73

Over 3 Years

down

-15.14

Over 5 Years

down

9.97

KOBO BIOTECH LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

KOBO BIOTECH LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
54.38
Promoter Holdings
44.94
FII
0.0
DII
0.66
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Arch Pharmalabs Ltd Shareholding of Promoter and Promoter Group 1.07091E7 44.95
Mehul Pravin Chandra Shah Public Shareholding 261696.0 1.1
Sanjay Luthra Public Shareholding 251861.0 1.06

KOBO BIOTECH LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2012-09-21 1.0 Final 2012-09-25 Equity shares 2011-07-22 1.0 Final 2011-07-26 Equity shares 2010-09-23 1.0 Final 2010-09-25 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About KOBO BIOTECH LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by KOBO BIOTECH LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Kobo Biotech Ltd?

Answer Field

The share price of Kobo Biotech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 3.49.

What is the Market Cap of Kobo Biotech Ltd?

Answer Field

The market cap of Kobo Biotech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 8.30 Cr. as of now.

What is the 52 Week High and Low of Kobo Biotech Ltd?

Answer Field

The 52 Week High and Low of Kobo Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 6.01 and ₹ 2.66.

How to Buy Kobo Biotech Ltd share?

Answer Field

You can trade in Kobo Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Kobo Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 6.73%.

What is the Current Share Price of Kobo Biotech Ltd?

Answer Field

Kobo Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 3.49 as on Dec 11 2024 03:21 PM.

What is the Market Cap of Kobo Biotech Ltd Share?

Answer Field

The market cap of Kobo Biotech Ltd for NSE ₹ 0.0 & for BSE ₹ 8.30 as on Dec 11 2024 03:21 PM.

What is the P/E Ratio of Kobo Biotech Ltd Share?

Answer Field

As on Dec 11 2024 03:21 PM the price-to-earnings (PE) ratio for Kobo Biotech Ltd share is -1.65.

What is the PB ratio of Kobo Biotech Ltd Share?

Answer Field

As on Dec 11 2024 03:21 PM, the price-to-book (PB) ratio for Kobo Biotech Ltd share is -55.78.

How to Buy Kobo Biotech Ltd Share?

Answer Field

You can trade in Kobo Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kobo Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Kobo Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kobo Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader